Zobrazeno 1 - 10
of 15
pro vyhledávání: '"I N, White"'
Autor:
I N, White
Publikováno v:
Pharmaceutical research. 1(4)
Compounds containing a terminal carbon-carbon triple bond, ranging in structure from the 17α-ethynyl substituted contraceptive steroids to acetylene gas, when administered to rats cause a selective and rapid time dependent loss of up to 50% of hepat
Autor:
J, Martin, I N, White
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 10
Morphologically, the lung is a complex organ containing over 40 different cell types (1). Although species and strain dependent, in the Fischer rat, the most common cell types include: endothelial, 33%; Type I, 6.5%; Type II, 12%; macrophages, 8%; ci
Autor:
I N, White, N, Razvi, A H, Gibbs, A M, Davies, M, Manno, C, Zaccaro, F, De Matteis, A, Pähler, W, Dekant
Publikováno v:
Toxicology letters. 124(1-3)
In this study, the metabolic activation of 2,2-dichloro-1,1,1-trifluoroethane (hydrochlorofluorocarbons-123, HCFC-123), halothane or 1,1-dichloro-1-fluoroethane (HCFC-141b) was compared to that of perchloroethylene, using lymphoblastoma derived cell
Autor:
L L, Smith, I N, White
Publikováno v:
Oncology (Williston Park, N.Y.). 12(3 Suppl 5)
Tamoxifen is by far the most clinically tested antiestrogenic drug currently used as adjuvant therapy for breast cancer and it continues to provide considerable benefit in this setting. The balance from clinical trials indicates a strong association
Publikováno v:
Cancer research. 57(7)
Tamoxifen, a rat liver carcinogen, was administered to female lambda/lacI transgenic rats at a dose of 20 mg/kg body weight by gavage for 6 weeks, and the animals were sacrificed 2 weeks later. Tamoxifen induced liver DNA adducts and caused a signifi
Publikováno v:
Progress in clinical and biological research. 396
Autor:
R, Davies, V I, Oreffo, S, Bayliss, P A, Dinh, K S, Lilley, I N, White, L L, Smith, J A, Styles
Publikováno v:
Environmental and molecular mutagenesis. 28(4)
Tamoxifen, an important drug in breast cancer treatment, causes liver cancer in rats. The standard range of in vitro tests have failed to show that it causes DNA damage, but 32P-postlabelling and DNA-binding studies have shown that tamoxifen forms DN
Autor:
P, Carthew, E A, Martin, I N, White, F, De Matteis, R E, Edwards, B M, Dorman, R T, Heydon, L L, Smith
Publikováno v:
Cancer research. 55(3)
Tamoxifen administered in the diet (420 ppm) to Wistar rats (TOX:P) for only 3 months caused cumulative hepatic DNA damage as assessed by 32P-postlabeling, consistent with the proposal that tamoxifen is a genotoxic carcinogen in this species. Promoti
Publikováno v:
European journal of pharmacology. 248(1)
C57Bl/10 mice were given halothane (10 mmol/kg, intraperitoneally) and microsomal proteins were analysed for the presence of trifluoroacetylated (TFA) neoantigens by SDS-gel electrophoresis followed by immunoblotting using a polyclonal anti-TFA antib
Autor:
F. De Matteis, David H. Phillips, A Hewer, I N White, Adrian M. Davies, Lewis L. Smith, Stanley Venitt, Christopher Crofton-Sleigh
Publikováno v:
Carcinogenesis. 13(12)
Chronic administration of tamoxifen to female rats causes hepatocellular carcinomas. We have investigated damage to liver DNA caused by the administration of tamoxifen to female Fischer F344/N rats or C57B1/6 or DBA/2 mice using 32P-postlabelling. Fo